Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma
Timothy F. Cloughesy(University of California, Los Angeles), Michael A. Vogelbaum(Moffitt Cancer Center), Derek Ostertag, Tobias Walbert(Henry Ford Health System), Tiffany T. Montellano(Kura Oncology (United States)), Clark C. Chen(Brown University), Daniela A. Bota(University of California, Irvine), Steven Brem(University of Pennsylvania), David Cachia(University of Massachusetts Chan Medical School), William P. Accomando(Retriev Technologies (United States)), Daniel J. Hogan(Retriev Technologies (United States)), Jay‐Jiguang Zhu(The University of Texas Health Science Center at Houston), Thian Kheoh(Janssen (United States)), David Piccioni(Center for Personalized Cancer Treatment), Lyndon Kim(Icahn School of Medicine at Mount Sinai), Chetan Bettegowda(Johns Hopkins University), Joseph Landolfi(Hackensack Meridian Health), Dimitris G. Placantonakis(New York University), Yaron A. Moshel(Overlook Medical Center), Aliz R. Rao(BioNano Genomics (United States)), Fábio M. Iwamoto(Columbia University), Nicholas Butowski(University of California, San Francisco), James Perry, Denise Damek(University of Colorado Anschutz Medical Campus), Michael Salacz(The University of Kansas Cancer Center), George Kaptain(Hackensack University Medical Center), Brad Elder(The Ohio State University), Fairooz F. Kabbinavar(Kaiser Permanente), Harry E. Gruber, Kevin Petrecca(McGill University Health Centre)
Cited by 141
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k